These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1456277)

  • 1. Ondansetron: pharmacology of a specific 5HT3-receptor antagonist.
    Deegan R
    Am J Med Sci; 1992 Dec; 304(6):373-8. PubMed ID: 1456277
    [No Abstract]   [Full Text] [Related]  

  • 2. [5HT3 antagonists: ondansetron].
    López de Ocariz A; Alvarez Medina P; Honorato J
    Rev Med Univ Navarra; 1993; 38(1):43-9. PubMed ID: 8711309
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary experience with use of a selective 5HT3 receptor antagonist (ondansetron) to prevent high dose chemotherapy induced emesis.
    Parikh PM; Shah SR; Shah SC; Sheth V; Patel RA; Shah KC; Jain PK
    Indian J Cancer; 1996 Mar; 33(1):17-20. PubMed ID: 9063013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of ondansetron. A review.
    Simpson KH; Hicks FM
    J Pharm Pharmacol; 1996 Aug; 48(8):774-81. PubMed ID: 8887724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system.
    Gupta D; Radhakrishnan M; Kurhe Y
    Eur J Pharmacol; 2014 Dec; 744():59-66. PubMed ID: 25284215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: modulation of hypothalamic-pituitary-adrenocortical and brain serotonergic system.
    Gupta D; Radhakrishnan M; Kurhe Y
    Pharmacol Biochem Behav; 2014 Sep; 124():129-36. PubMed ID: 24909071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal obstruction in pregnancy by ondansetron.
    Cohen R; Shlomo M; Dil DN; Dinavitser N; Berkovitch M; Koren G
    Reprod Toxicol; 2014 Dec; 50():152-3. PubMed ID: 25461913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migraine-type headaches in children receiving chemotherapy and ondansetron.
    Khan RB
    J Child Neurol; 2002 Nov; 17(11):857-8. PubMed ID: 12585731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications.
    Wilde MI; Markham A
    Drugs; 1996 Nov; 52(5):773-94. PubMed ID: 9118822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal obstruction is a rare complication of ondansetron exposure in hyperemesis gravidarum.
    Fejzo MS; MacGibbon K; Mullin P
    Reprod Toxicol; 2015 Nov; 57():207. PubMed ID: 26196894
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of ondansetron, a 5-HT3 receptor antagonist, as a new type of antiemetic in pediatric oncology].
    Csáki C; Ferencz T; Koós R; Schuler D; Borsi J
    Orv Hetil; 1993 Jun; 134(25):1363-7. PubMed ID: 8332356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
    Goldsmith B
    Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626
    [No Abstract]   [Full Text] [Related]  

  • 13. Ondansetron: reasons to be restrictive.
    Frigerio C; Buchwalder PA; Spertini F
    Lancet; 1996 May; 347(9013):1484-5. PubMed ID: 8676652
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy, safety and effectiveness of ondansetron compared to other serotonin-3 receptor antagonists (5-HT3RAs) used to control chemotherapy-induced nausea and vomiting: systematic review and meta-analysis.
    Simino GP; Marra LP; Andrade EI; Acúrcio Fde A; Reis IA; De Araújo VE; Cherchiglia ML
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1183-94. PubMed ID: 27180992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness.
    Levine ME; Chillas JC; Stern RM; Knox GW
    Aviat Space Environ Med; 2000 Nov; 71(11):1111-4. PubMed ID: 11086664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic mechanism in imipramine induced antinociception in rat tail flick test.
    Bhargava VK; Saha L
    Indian J Physiol Pharmacol; 2001 Jan; 45(1):107-10. PubMed ID: 11211562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute postoperative pancreatitis, is it associated with the use of ondansetron?].
    Granados LM; Ballester F; Suárez F; Sánchez-Peña J; Navas E
    Rev Esp Anestesiol Reanim; 1997 Feb; 44(2):87. PubMed ID: 9148363
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent bowel occlusion with oral ondansetron with no side effects of the intravenous route: a previously unknown adverse event.
    Lebrun C; Chichmanian RM; Peyrade F; Chatel M; Frenay M
    Ann Oncol; 1997 Sep; 8(9):919-20. PubMed ID: 9358948
    [No Abstract]   [Full Text] [Related]  

  • 19. Administration of a 5HT3 receptor antagonist increases the intake of diets containing Eucalyptus secondary metabolites by marsupials.
    Lawler IR; Foley WJ; Pass GJ; Eschler BM
    J Comp Physiol B; 1998 Dec; 168(8):611-8. PubMed ID: 9871345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed diagnosis of anaphylaxis secondary to ondansetron: A case report.
    Goyal P; Paramesh K; Puranik S; Proctor M; Sanghvi M
    Eur J Anaesthesiol; 2016 Feb; 33(2):146-7. PubMed ID: 26555872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.